EG i23
Alternative Names: EG-i23Latest Information Update: 04 Feb 2021
At a glance
- Originator enGene
- Class Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Unspecified
Most Recent Events
- 01 Jan 2021 Early research in Unspecified in Canada (Intranasal) (enGene pipeline, January 2021)